STAFFORD, UK, October 8, 2007-PuriCore (LSE: PURI), the life sciences company focused on the control of infectious pathogens, today announces that the US Patent and Trademark Office has granted US Patent No. 7,276,255, entitled Wound and Ulcer Treatment with Super-Oxidized Water relating to wound therapy methods. PuriCore’s methods employ hypochlorous acid at neutral or near-neutral pH to enhance the healing process for wounds. Related patents have been approved previously for PuriCore’s technology in the UK and Europe.
